EA
ONCE

Emerald Acquisition’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History

Emerald Acquisition’s Portfolio ONCE Stock Details ONCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		$812K Buy
13,529
+1,157
+9% +$66.7K ﹤0.01% 2231
2016
Q2 		$633K Buy
+12,372
New +$529K ﹤0.01% 2382

Other funds holding ONCE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Emerald Acquisition's ONCE Position: Q3 2016 in Review

Emerald Acquisition increased its Spark Therapeutics, Inc. Common Stock (ONCE) stake by 9.4% in Q3 2016, buying an estimated $66.7K and bringing the position to 13,529 shares worth $812K. The position accounts for ﹤0.01% of the portfolio, ranked #2231.

Emerald Acquisition first reported a position in ONCE in Q2 2016 and has held it in 2 quarters since. 121 funds tracked by Wall St. Rank hold ONCE as of Q3 2016.

  • Emerald Acquisition held 13,529 shares of Spark Therapeutics, Inc. Common Stock worth $812K as of Q3 2016.
  • Emerald Acquisition bought 1,157 Spark Therapeutics, Inc. Common Stock shares in Q3 2016, an estimated $66.7K.
  • Spark Therapeutics, Inc. Common Stock made up ﹤0.01% of Emerald Acquisition's portfolio in Q3 2016, its #2231 holding.
  • Emerald Acquisition first reported a position in Spark Therapeutics, Inc. Common Stock in Q2 2016 and has held it in 2 quarters since.
  • 121 funds tracked by Wall St. Rank held Spark Therapeutics, Inc. Common Stock as of Q3 2016.

Based on Emerald Acquisition's 13F filing for Q3 2016, filed 9 Nov 2016.